Stock Track | 10x Genomics Soars 9.94% in Pre-Market on Multiple Analyst Target Price Raises

Stock Track
02/13

10x Genomics Inc (TXG) saw its stock price surge 9.94% during pre-market trading, indicating strong investor interest ahead of the regular session.

The significant price movement follows a series of positive analyst actions, with multiple financial institutions raising their target prices for the genomics company. Deutsche Bank increased its target to $17 from $16, JP Morgan raised to $17 from $15, Jefferies lifted to $21 from $17, Stifel boosted to $20 from $15, and TD Cowen moved to $19 from $18.

These coordinated analyst upgrades suggest growing optimism about 10x Genomics' business prospects and future performance, driving increased buying activity in the pre-market session.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10